Cargando…
(−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
Liver cancers, such as hepatocellular carcinoma (HCC), are a highly prevalent cause of cancer-related deaths. Current treatments to combat liver cancer are limited. (−)-Agelasidine A, a compound isolated from the methanol extract of Agelas nakamurai, a sesquiterpene guanidine derived from sea sponge...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875608/ https://www.ncbi.nlm.nih.gov/pubmed/35200638 http://dx.doi.org/10.3390/md20020109 |
_version_ | 1784657973456404480 |
---|---|
author | Lu, I-Ta Lin, Shih-Chao Chu, Yi-Chia Wen, Ya Lin, You-Cheng Cheng, Wen-Chien Sheu, Jyh-Horng Lin, Chi-Chien |
author_facet | Lu, I-Ta Lin, Shih-Chao Chu, Yi-Chia Wen, Ya Lin, You-Cheng Cheng, Wen-Chien Sheu, Jyh-Horng Lin, Chi-Chien |
author_sort | Lu, I-Ta |
collection | PubMed |
description | Liver cancers, such as hepatocellular carcinoma (HCC), are a highly prevalent cause of cancer-related deaths. Current treatments to combat liver cancer are limited. (−)-Agelasidine A, a compound isolated from the methanol extract of Agelas nakamurai, a sesquiterpene guanidine derived from sea sponge, has antibacterial activity. We demonstrated its anticancer capabilities by researching the associated mechanism of (−)-agelasidine A in human liver cancer cells. We found that (−)-agelasidine A significantly reduced viability in Hep3B and HepG2 cells, and we determined that apoptosis was involved in the (−)-agelasidine A-induced Hep3B cell deaths. (−)-Agelasidine A activated caspases 9, 8, and 3, as well as PARP. This effect was reversed by caspase inhibitors, suggesting caspase-mediated apoptosis in the (−)-agelasidine A-treated Hep3B cells. Moreover, the reduced mitochondrial membrane potential (MMP) and the release of cytochrome c indicated that the (−)-agelasidine A-mediated mitochondrial apoptosis was mechanistic. (−)-Agelasidine A also increased apoptosis-associated proteins (DR4, DR5, FAS), which are related to extrinsic pathways. These events were accompanied by an increase in Bim and Bax, proteins that promote apoptosis, and a decrease in the antiapoptotic protein, Bcl-2. Furthermore, our results presented that (−)-agelasidine A treatment bridged the intrinsic and extrinsic apoptotic pathways. Western blot analysis of Hep3B cells treated with (−)-agelasidine A showed that endoplasmic reticulum (ER) stress-related proteins (GRP78, phosphorylated PERK, phosphorylated eIF2α, ATF4, truncated ATF6, and CHOP) were upregulated. Moreover, 4-PBA, an ER stress inhibitor, could also abrogate (−)-agelasidine A-induced cell viability reduction, annexin V+ apoptosis, death receptor (DR4, DR5, FAS) expression, mitochondrial dysfunction, and cytochrome c release. In conclusion, by activating ER stress, (−)-agelasidine A induced the extrinsic and intrinsic apoptotic pathways of human HCC. |
format | Online Article Text |
id | pubmed-8875608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88756082022-02-26 (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma Lu, I-Ta Lin, Shih-Chao Chu, Yi-Chia Wen, Ya Lin, You-Cheng Cheng, Wen-Chien Sheu, Jyh-Horng Lin, Chi-Chien Mar Drugs Article Liver cancers, such as hepatocellular carcinoma (HCC), are a highly prevalent cause of cancer-related deaths. Current treatments to combat liver cancer are limited. (−)-Agelasidine A, a compound isolated from the methanol extract of Agelas nakamurai, a sesquiterpene guanidine derived from sea sponge, has antibacterial activity. We demonstrated its anticancer capabilities by researching the associated mechanism of (−)-agelasidine A in human liver cancer cells. We found that (−)-agelasidine A significantly reduced viability in Hep3B and HepG2 cells, and we determined that apoptosis was involved in the (−)-agelasidine A-induced Hep3B cell deaths. (−)-Agelasidine A activated caspases 9, 8, and 3, as well as PARP. This effect was reversed by caspase inhibitors, suggesting caspase-mediated apoptosis in the (−)-agelasidine A-treated Hep3B cells. Moreover, the reduced mitochondrial membrane potential (MMP) and the release of cytochrome c indicated that the (−)-agelasidine A-mediated mitochondrial apoptosis was mechanistic. (−)-Agelasidine A also increased apoptosis-associated proteins (DR4, DR5, FAS), which are related to extrinsic pathways. These events were accompanied by an increase in Bim and Bax, proteins that promote apoptosis, and a decrease in the antiapoptotic protein, Bcl-2. Furthermore, our results presented that (−)-agelasidine A treatment bridged the intrinsic and extrinsic apoptotic pathways. Western blot analysis of Hep3B cells treated with (−)-agelasidine A showed that endoplasmic reticulum (ER) stress-related proteins (GRP78, phosphorylated PERK, phosphorylated eIF2α, ATF4, truncated ATF6, and CHOP) were upregulated. Moreover, 4-PBA, an ER stress inhibitor, could also abrogate (−)-agelasidine A-induced cell viability reduction, annexin V+ apoptosis, death receptor (DR4, DR5, FAS) expression, mitochondrial dysfunction, and cytochrome c release. In conclusion, by activating ER stress, (−)-agelasidine A induced the extrinsic and intrinsic apoptotic pathways of human HCC. MDPI 2022-01-29 /pmc/articles/PMC8875608/ /pubmed/35200638 http://dx.doi.org/10.3390/md20020109 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, I-Ta Lin, Shih-Chao Chu, Yi-Chia Wen, Ya Lin, You-Cheng Cheng, Wen-Chien Sheu, Jyh-Horng Lin, Chi-Chien (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma |
title | (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma |
title_full | (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma |
title_fullStr | (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma |
title_full_unstemmed | (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma |
title_short | (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma |
title_sort | (−)-agelasidine a induces endoplasmic reticulum stress-dependent apoptosis in human hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875608/ https://www.ncbi.nlm.nih.gov/pubmed/35200638 http://dx.doi.org/10.3390/md20020109 |
work_keys_str_mv | AT luita agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT linshihchao agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT chuyichia agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT wenya agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT linyoucheng agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT chengwenchien agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT sheujyhhorng agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma AT linchichien agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma |